US 8969367
Crystalline forms of a 3-carboxypropyl-aminotetralin compound
granted A61PA61P1/00A61P1/14
Quick answer
US patent 8969367 (Crystalline forms of a 3-carboxypropyl-aminotetralin compound) held by Theravance Biopharma R&D IP, LLC expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P1/00, A61P1/14, A61P25/04, A61P29/00